Status:

COMPLETED

Randomized Trial of Web-Delivered Acceptance Therapy for Smoking Cessation (WebQuit)

Lead Sponsor:

Fred Hutchinson Cancer Center

Collaborating Sponsors:

Kaiser Permanente

National Cancer Institute (NCI)

Conditions:

Smoking

Eligibility:

All Genders

18-99 years

Phase:

NA

Brief Summary

The goal of this study is to determine whether the ACT website provides higher quit rates than a current standard smoking cessation website.

Eligibility Criteria

Inclusion

  • age 18 or older
  • smokes at least five cigarettes daily for at least past 12 months
  • wants to quit in next 30 days
  • willing to be randomly assigned to either group
  • resides in US
  • has at least weekly access to a high speed Internet connection and email
  • willing and able to read in English
  • not participating in other smoking cessation interventions (including our other intervention studies
  • has never used the Smokefree.gov website
  • willing to complete all three follow-up surveys
  • provide email, phone, and mailing address
  • provide contact information for two collaterals (e.g., relatives).
  • does not have family, friends, or other household members participating

Exclusion

  • The exclusion criteria are the opposite of the inclusion criteria above.

Key Trial Info

Start Date :

March 24 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 31 2019

Estimated Enrollment :

2637 Patients enrolled

Trial Details

Trial ID

NCT01812278

Start Date

March 24 2014

End Date

December 31 2019

Last Update

July 31 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Fred Hutchinson Cancer Research Center

Seattle, Washington, United States, 98109